Insulin resistance contributes more to the increased risk for diabetes development in subjects with low lipoprotein(a) level than insulin secretion

PloS One
Eun-Jung RheeWon-Young Lee

Abstract

Recent studies suggest an association between Lipoprotein(a) [Lp(a)] and the development of diabetes mellitus. We analyzed the association between baseline Lp(a) levels and diabetes development after 4 years of follow-up, in a population of apparently healthy Korean subjects. A total of 2,536 non-diabetic participants (mean age: 41 years, men: 92%) of a health checkup program were included in the study. Diabetes development was defined by fasting blood glucose ≥126 mg/dL, HbA1c ≥6.5%, and self-reported treatment of diabetes. Homeostasis model assessment (HOMA) indices were used to assess insulin resistance (IR) and insulin secretion (IS). Presence of IR and impaired IS was defined by being in the highest quartile of HOMA-IR and in the lowest quartile HOMA-IS. After four years, 3.4% of the participants developed diabetes. The odds ratio (OR) of developing diabetes was lowest in the 4th quartile group of baseline Lp(a) (0.323 [95% CI 0.153-0.685])with the 1st quartile group as the reference. The subjects with both IR & impaired IS plus baseline Lp(a)<50 mg/dL showed the higher OR for diabetes development compared with those without IR and normal IS as the reference (67.277 [20.218-223.871], and those with IR plus Lp(a)<50 mg/dL s...Continue Reading

References

Jun 1, 1992·Journal of Internal Medicine·A M Scanu
Apr 1, 1991·Diabetes Care·S M HaffnerD L Rainwater
May 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·L B NielsenB G Nordestgaard
Aug 26, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·D L Rainwater, S M Haffner
Jan 1, 1963·Acta Pathologica Et Microbiologica Scandinavica·K BERG
Apr 9, 2005·Journal of Pediatric Endocrinology & Metabolism : JPEM·Paulina BustosSylvia Asenjo
Jul 15, 2005·BMC Family Practice·Kendra L SchwartzAnne Victoria Neale
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Oct 20, 2009·Arquivos brasileiros de cardiologia·Syed Shahid HabibAbdul Khaliq Naveed
Jun 1, 2010·Clinical Chemistry·Samia MoraPaul M Ridker
Mar 17, 2012·Medicinal Chemistry·Z BacováV Strbák
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Pia R Kamstrup, Børge G Nordestgaard
Feb 18, 2016·PloS One·Masayuki WadaShunichi Kumakura
Jan 11, 2017·Journal of Diabetes·Payal H MaratheKelly L Close

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.